Physician Practice

Look to "Blueprint" to understand new EPA requirements on hazardous drug waste

Medical Environment Update, March 1, 2019

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Medical Environment Update.

Consider managing all your pharmaceuticals as hazardous waste, especially if you are a smaller facility. And warn your C-suite that you’ll be scrutinized for compliance once new environmental regulations take effect.

The Environmental Protection Agency (EPA) has put a lot of time and effort into revising the federal Resource Conservation and Recovery Act (RCRA). They will want to see facilities implementing the newly finalized “Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine,” says Charlotte A. Smith, RPh, MS, a senior regulatory advisor and founder of PharmEcology Services, now a part of WM Sustainability Services.

The final rule will become effective six months after it is published in the Federal Register. While the pre-published version was signed and posted on the EPA’s website, as of late January it had not been officially posted in the Federal Register. 

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Medical Environment Update.

Most Popular